"Biomarkers" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc.
| Descriptor ID |
D015415
|
| MeSH Number(s) |
D23.101
|
| Concept/Terms |
Biomarkers- Biomarkers
- Markers, Biological
- Biologic Markers
- Markers, Biologic
- Biologic Marker
- Marker, Biologic
- Marker, Biological
- Biological Marker
- Biological Markers
Serum Markers- Serum Markers
- Markers, Serum
- Marker, Serum
- Serum Marker
Surrogate Endpoints- Surrogate Endpoints
- Endpoints, Surrogate
- Surrogate End Points
- End Points, Surrogate
- Surrogate End Point
- End Point, Surrogate
- Surrogate Endpoint
- Endpoint, Surrogate
Viral Markers- Viral Markers
- Markers, Viral
- Viral Marker
- Marker, Viral
Biochemical Marker- Biochemical Marker
- Biochemical Markers
- Markers, Biochemical
- Marker, Biochemical
Markers, Immunologic- Markers, Immunologic
- Immune Markers
- Markers, Immune
- Marker, Immunologic
- Immunologic Markers
- Immune Marker
- Marker, Immune
- Immunologic Marker
Surrogate Markers- Surrogate Markers
- Markers, Surrogate
- Marker, Surrogate
- Surrogate Marker
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers".
This graph shows the total number of publications written about "Biomarkers" by people in this website by year, and whether "Biomarkers" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 8 | 8 |
| 1997 | 1 | 4 | 5 |
| 1998 | 0 | 6 | 6 |
| 1999 | 0 | 7 | 7 |
| 2000 | 1 | 11 | 12 |
| 2001 | 3 | 13 | 16 |
| 2002 | 0 | 10 | 10 |
| 2003 | 3 | 14 | 17 |
| 2004 | 2 | 12 | 14 |
| 2005 | 2 | 18 | 20 |
| 2006 | 0 | 18 | 18 |
| 2007 | 1 | 27 | 28 |
| 2008 | 4 | 37 | 41 |
| 2009 | 6 | 28 | 34 |
| 2010 | 8 | 36 | 44 |
| 2011 | 12 | 47 | 59 |
| 2012 | 10 | 54 | 64 |
| 2013 | 16 | 61 | 77 |
| 2014 | 10 | 63 | 73 |
| 2015 | 7 | 72 | 79 |
| 2016 | 13 | 71 | 84 |
| 2017 | 12 | 77 | 89 |
| 2018 | 10 | 92 | 102 |
| 2019 | 15 | 86 | 101 |
| 2020 | 14 | 74 | 88 |
| 2021 | 15 | 89 | 104 |
| 2022 | 1 | 46 | 47 |
| 2023 | 3 | 58 | 61 |
| 2024 | 22 | 35 | 57 |
| 2025 | 8 | 45 | 53 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers" by people in Profiles.
-
Poor olfaction and risk of heart failure in the Atherosclerosis Risk in Communities Study. J Gerontol A Biol Sci Med Sci. 2025 Oct 05; 80(11).
-
Impact of PlGF immunoassay imprecision on preeclampsia risk assessment with the sFlt-1 to PlGF ratio. Am J Clin Pathol. 2025 Aug 26; 164(2):200-206.
-
Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis. Clin Neurophysiol. 2025 Nov; 179:2110986.
-
Differentiating biomarker features and familial characteristics of B-SNIP psychosis Biotypes. Transl Psychiatry. 2025 Aug 14; 15(1):281.
-
Modification of the Cardiac Renal Angina Index for Predicting Adverse Kidney Events After Pediatric Cardiac Surgery. J Am Heart Assoc. 2025 Aug 19; 14(16):e042941.
-
Phosphatidylethanol in steatotic liver disease. J Hepatol. 2025 Nov; 83(5):1189-1203.
-
Proteomic Biomarkers of Survival in Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Disease. Am J Respir Crit Care Med. 2025 Aug; 211(8):1452-1462.
-
Clustering Patients with Pulmonary Hypertension Using the Plasma Proteome. Am J Respir Crit Care Med. 2025 Aug; 211(8):1492-1503.
-
Validation of a Longitudinal Marker as a Surrogate Using Mediation Analysis and Joint Modeling: Evolution of the PSA as a Surrogate of the Disease-Free Survival. Biom J. 2025 Aug; 67(4):e70064.
-
Associations between donor-derived cell-free DNA dynamics and clinical outcomes after kidney allograft rejection: A prospective, multicenter study. Am J Transplant. 2025 Dec; 25(12):2543-2553.